XML 27 R44.htm IDEA: XBRL DOCUMENT v3.20.1
Summary of Significant Accounting Policies - Additional Information (Detail)
3 Months Ended 12 Months Ended
Sep. 30, 2019
USD ($)
Dec. 31, 2019
USD ($)
Segment
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Jan. 01, 2019
USD ($)
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]          
Number of operating segment | Segment   1      
Cash, cash equivalents and marketable securities   $ 151,100,000      
Impairment of Intangible assets   0 $ 0 $ 0  
Accelerated depreciation related to certain long-lived assets $ 3,000,000.0 3,000,000.0      
Right-of-use asset   30,252,000      
Operating lease, liability   40,884,000      
Goodwill impairment   $ 0 $ 0 $ 0  
ASC 842          
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]          
Right-of-use asset         $ 34,800,000
Operating lease, liability         $ 37,100,000
Credit Concentration Risk          
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]          
Concentration risk, customer   three largest customers three largest customers    
Trade Receivable | Credit Concentration Risk          
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]          
Concentration risk, percentage   76.00% 71.00%    
Product | Revenue | Credit Concentration Risk          
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]          
Concentration risk, percentage   62.00% 68.00%    
United States          
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]          
Percentage of revenue earned   100.00% 83.00% 90.00%  
Percentage of long lived assets   62.00% 24.00%    
Maximum          
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]          
Cash equivalents original maturity period   3 months      
Expected period of payment to be received   1 year      
Dynavax GmbH          
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]          
Currency translation adjustments   $ (500,000) $ (1,100,000) $ 2,800,000  
Currency transaction gain (loss)   $ 200,000 $ 300,000 $ (600,000)